Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia
Clinical trial NCT02736955 · COMPLETED
Trial details
- NCT number
- NCT02736955
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-13
- Primary completion
- 2017-06-30
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.